Global Anti-Venom Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Anti-Venom Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.

According to our (Global Info Research) latest study, the global Anti-Venom market size was valued at US$ 1032 million in 2023 and is forecast to a readjusted size of USD 1363 million by 2030 with a CAGR of 4.1% during review period.

CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.

This report is a detailed and comprehensive analysis for global Anti-Venom market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Anti-Venom market size and forecasts, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2019-2030

Global Anti-Venom market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2019-2030

Global Anti-Venom market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2019-2030

Global Anti-Venom market shares of main players, shipments in revenue ($ Million), sales quantity (K Vials), and ASP (USD/Vial), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Anti-Venom

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Anti-Venom market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Anti-Venom market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Polyvalent Anti-Venom
Monovalent Anti-Venom

Market segment by Application
Non-profit Institutions
Hospitals and Clinic

Major players covered
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Anti-Venom product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Anti-Venom, with price, sales quantity, revenue, and global market share of Anti-Venom from 2019 to 2024.

Chapter 3, the Anti-Venom competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Anti-Venom breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Anti-Venom market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-Venom.

Chapter 14 and 15, to describe Anti-Venom sales channel, distributors, customers, research findings and conclusion.